Inventor
RYAN E. MICHAEL
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07DHeterocyclic compounds27%
C07JSteroids9%
Y02ATechnologies for adaptation to climate change9%
PatentTitleYear
12,486,290Isoindolinone and indazole compounds for the degradation of EGFR202512,371,442Isoindolinone and indazole compounds for the degradation of EGFR202512,076,405Heterocyclic degronimers for target protein degradation202412,048,748Spirocyclic degronimers for target protein degradation202411,673,902Isoindolinone and indazole compounds for the degradation of EGFR202311,185,592Spirocyclic degronimers for target protein degradation2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to C4 THERAPEUTICS INC (6)· patent assignee history
2021–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| C4 THERAPEUTICS INC | 6 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2021–2025 |